Delivery Order SPE2DB20D1100-SPE2DB24FZ74C
Award Date 1/16/24
Potential Completion Date 1/17/24
Potential Value $31K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order valued at $2,540.23, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of February 9, 2024. The contract type is firm fixed price. Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical products and medical supplies...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $96,723.41, is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 6, 2022 and is a Firm Fixed Price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,964.95 and an ultimate completion date of June 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award, SPE2DB20D1109|SPE2DB24FN93Z, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,850.98 firm fixed price delivery order is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,570.31 firm fixed-price delivery order is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of February 12, 2025. The contract is not designated as a set-aside and was awarded as part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award, valued at $30,965.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,730.01 and an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself...
- This federal contract award, valued at $20,646.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The award is not associated with a set-aside program and is a firm fixed-price contract scheduled for completion by December 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,094.18, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 14, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,883.81 award is for the provision of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of January 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has previously received numerous federal contract awards from...